Company / Financials
Bio Essence Corp Financials
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$1.9M
FY2025 · +485.8% YoY
Net Income
$896.2K
FY2025 · +168.5% YoY
Profit Margin
47.2%
FY2025 · net income / revenue
ROE
-
FY2025 · return on equity
Total Assets
$422.5K
FY2025
Total Debt
$57.5K
-0.03x debt/equity
Equity
-$2.1M
FY2025
ROA
212.1%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High Piotroski F-Score: 9/9 (strong financial health signals)
- Altman Z-Score -11.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$1.9M+485.8% YoYNet Income HistoryProfit after all expenses and taxes$896.2K+168.5% YoYGross Profit HistoryRevenue minus cost of goods sold$1.4M+558.0% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$469.2K+339.0% YoYOperating Income HistoryProfit from core business operations before interest and taxes$900.0K+295.9% YoYSG&A Expense HistorySelling, general, and administrative expenses$497.8K-26.4% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$8000.0% YoYEPS (Basic) HistoryBasic earnings per share-EPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-